TIAA CREF INVESTMENT MANAGEMENT LLC - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 45 filers reported holding OBALON THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$83,000
-48.1%
24,1770.0%0.00%
Q4 2017$160,000
-31.6%
24,177
-1.7%
0.00%
Q3 2017$234,0000.0%24,584
+4.3%
0.00%
Q2 2017$234,000
+470.7%
23,577
+511.8%
0.00%
Q1 2017$41,000
+20.6%
3,8540.0%0.00%
Q4 2016$34,0003,8540.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$21,712,0005.18%
Tamarack Advisers, LP 562,606$4,979,0003.52%
WALL STREET ASSOCIATES 99,700$882,0000.58%
Pier Capital, LLC 253,077$2,240,0000.40%
FORMULA GROWTH LTD 74,998$664,0000.15%
Bellevue Group AG 40,000$354,0000.07%
KORNITZER CAPITAL MANAGEMENT INC /KS 417,230$3,692,0000.07%
PEREGRINE CAPITAL MANAGEMENT LLC 286,750$2,538,0000.07%
WASATCH ADVISORS LP 253,284$2,242,0000.03%
C WorldWide Group Holding A/S 100,000$885,0000.02%
View complete list of OBALON THERAPEUTICS INC shareholders